ALFA FinderBSE filing, NSE: VIVOBIOT. Summary written from the filing by ALFA Finder's alert engine.
Vivo Bio Tech Ltd: key numbers
- Share price
- ₹16.22
- Market cap
- ₹26.16 Cr
- Revenue (annual)
- ₹53.33 Cr
- Net profit (annual)
- ₹-1.71 Cr
- P/E (TTM)
- -10.0×Sector 43.8×
- Promoter holding
- 22.51%-8.11% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vivo Bio Tech Ltd
All →Vivo Bio Tech Q2 FY27 Results: Net Profit ₹1.1 Cr, Up 22.2% YoY
Vivo Bio Tech Ltd reported revenue from operations of ₹17.2 Cr (+31.3% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.1 Cr · +22.2% YoY
Vivo Bio Tech Board Meeting Date
Vivo Bio Tech has scheduled a board meeting for November 11, 2026, to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until 48 hours after results declaration.
Vivo Bio Tech Other Announcement
The company submitted its periodic shareholding pattern for the quarter ended September 30, 2026, disclosing its promoter and public shareholding as mandated by SEBI.
Vivo Bio Tech Adverse Business Impact
Vivo Bio Tech reports a fire at its Telangana research facility damaging labs, equipment, and samples. No casualties; damage under assessment with adequate insurance coverage in place.
Vivo Bio Tech Other Announcement
Vivo Bio Tech Ltd filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Vivo Bio Tech Management Change
Vivo Bio Tech Limited announced the re-appointment of Sri Kalyan Kompella and Sankaranarayanan Alangudi as Executive Directors, effective November 2026 and January 2027 respectively.
Other other announcement announcements
All →Turtlemint Fintech Solutions Other Announcement
CARE Ratings confirmed Turtlemint's IPO proceeds were used per the offer document, with no deviation, for the quarter ended September 30, 2026. This is SEBI-mandated monitoring disclosure.
Praxis Home Retail Other Announcement
Praxis Home Retail disclosed that CBI registered a bank fraud case against Future Retail, whose promoter Kishore Biyani also promotes Praxis. The company states no direct financial or operational impact.
Deepak Builders & Engineers India Other Announcement
Deepak Builders filed Crisil's monitoring agency report on IPO proceeds for the quarter ended 30 September 2026. The report shows no deviation from the stated objects of the issue.
Oswal Pumps Other Announcement
Oswal Pumps filed ICRA's final IPO proceeds monitoring report for Q2 FY2027. ICRA found no material deviation, but flagged capex purchases not matching prospectus vendor specifications.
Hitachi Energy India Other Announcement
Hitachi Energy India reported no deviation in its QIP fund use for the quarter ended September 30, 2026. Utilisation matches the placement document objects.
Global Pet Industries Other Announcement
Global Pet Industries reported no deviation in IPO and preferential issue fund utilisation for the half year ended September 2026. The Audit Committee reviewed the statement.